ASN's Mission

To create a world without kidney diseases, the ASN Alliance for Kidney Health elevates care by educating and informing, driving breakthroughs and innovation, and advocating for policies that create transformative changes in kidney medicine throughout the world.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on X

Kidney Week

Educational Symposium

What's New with SGLT2 Inhibitors in 2023

November 02, 2023 | 12:45 PM - 01:45 PM

Location: Grand Ballroom Salon A, Level 5, Philadelphia Marriott Downtown

Session Description

Sodium-glucose cotransporter 2 (SGLT2) inhibitors have demonstrated beneficial effects in clinical trials on kidney-related, cardiovascular, and heart failure outcomes in CKD patients with and without type 2 diabetes and in patients with heart failure. The application of these therapeutics only continues to expand. Importantly, there have been other recent novel therapies in the CKD therapeutic arena. There is now an opportunity to move toward "goal-directed medical therapy" in CKD.

This symposium reviews what's new in 2023 with SGLT2 inhibitors and how to approach use of these medications in the context of established and newer therapeutics. Additionally, this symposium reviews the practice tips and potential pitfalls in prescribing these medications in practice.

Support is provided by an educational grant from AstraZeneca.

Learning Objective(s)

  • Discuss the newest data on SGLT2 inhibitors, including patients that are good candidates
  • Describe effective approaches and possible challenges in the real-world prescribing of these medications
  • Develop an approach to prescribing these medications in combination with other CKD medications

Learning Pathway(s)

  • CKD Non-Dialysis
  • Diabetic Kidney Disease